359 related articles for article (PubMed ID: 35008971)
1. Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets?
Avci E; Sarvari P; Savai R; Seeger W; Pullamsetti SS
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008971
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension in chronic lung diseases.
Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis.
Strykowski R; Adegunsoye A
Immunol Allergy Clin North Am; 2023 May; 43(2):209-228. PubMed ID: 37055085
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation in chronic obstructive pulmonary disease.
Huo X; Jin S; Wang Y; Ma L
Epigenomics; 2021 Jul; 13(14):1145-1155. PubMed ID: 34142873
[TBL] [Abstract][Full Text] [Related]
5. NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease.
Szema AM; Forsyth E; Ying B; Hamidi SA; Chen JJ; Hwang S; Li JC; Sabatini Dwyer D; Ramiro-Diaz JM; Giermakowska W; Gonzalez Bosc LV
PLoS One; 2017; 12(1):e0170606. PubMed ID: 28125639
[TBL] [Abstract][Full Text] [Related]
6. A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis.
Coward WR; Feghali-Bostwick CA; Jenkins G; Knox AJ; Pang L
FASEB J; 2014 Jul; 28(7):3183-96. PubMed ID: 24652950
[TBL] [Abstract][Full Text] [Related]
7. Cellular senescence and autophagy in the pathogenesis of chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF).
Kuwano K; Araya J; Hara H; Minagawa S; Takasaka N; Ito S; Kobayashi K; Nakayama K
Respir Investig; 2016 Nov; 54(6):397-406. PubMed ID: 27886850
[TBL] [Abstract][Full Text] [Related]
8. Glutaminolysis Epigenetically Regulates Antiapoptotic Gene Expression in Idiopathic Pulmonary Fibrosis Fibroblasts.
Bai L; Bernard K; Tang X; Hu M; Horowitz JC; Thannickal VJ; Sanders YY
Am J Respir Cell Mol Biol; 2019 Jan; 60(1):49-57. PubMed ID: 30130138
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Regulation of Caveolin-1 Gene Expression in Lung Fibroblasts.
Sanders YY; Liu H; Scruggs AM; Duncan SR; Huang SK; Thannickal VJ
Am J Respir Cell Mol Biol; 2017 Jan; 56(1):50-61. PubMed ID: 27560128
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
11. Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model.
Selman M; Pardo A
Am J Respir Crit Care Med; 2014 May; 189(10):1161-72. PubMed ID: 24641682
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathways and role of epigenetics in the idiopathic pulmonary fibrosis.
Velagacherla V; Mehta CH; Nayak Y; Nayak UY
Life Sci; 2022 Feb; 291():120283. PubMed ID: 34998839
[TBL] [Abstract][Full Text] [Related]
13. Exploring the cross-phenotype network region of disease modules reveals concordant and discordant pathways between chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Halu A; Liu S; Baek SH; Hobbs BD; Hunninghake GM; Cho MH; Silverman EK; Sharma A
Hum Mol Genet; 2019 Jul; 28(14):2352-2364. PubMed ID: 30997486
[TBL] [Abstract][Full Text] [Related]
14. Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD.
Ishikawa N; Ohlmeier S; Salmenkivi K; Myllärniemi M; Rahman I; Mazur W; Kinnula VL
Respir Res; 2010 Sep; 11(1):123. PubMed ID: 20836851
[TBL] [Abstract][Full Text] [Related]
15. Epigenetics in asthma and COPD.
Kabesch M; Adcock IM
Biochimie; 2012 Nov; 94(11):2231-41. PubMed ID: 22874820
[TBL] [Abstract][Full Text] [Related]
16. Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).
Khedoe P; Marges E; Hiemstra P; Ninaber M; Geelhoed M
Front Immunol; 2020; 11():1990. PubMed ID: 33013852
[TBL] [Abstract][Full Text] [Related]
17. Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer.
Tzouvelekis A; Gomatou G; Bouros E; Trigidou R; Tzilas V; Bouros D
Chest; 2019 Aug; 156(2):383-391. PubMed ID: 31125557
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomic characterization of the lung extracellular matrix in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Åhrman E; Hallgren O; Malmström L; Hedström U; Malmström A; Bjermer L; Zhou XH; Westergren-Thorsson G; Malmström J
J Proteomics; 2018 Oct; 189():23-33. PubMed ID: 29501846
[TBL] [Abstract][Full Text] [Related]
19. Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis.
Aoshima Y; Enomoto Y; Muto S; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
Lung; 2021 Jun; 199(3):289-298. PubMed ID: 33770226
[TBL] [Abstract][Full Text] [Related]
20. Increased Expression of CC16 in Patients with Idiopathic Pulmonary Fibrosis.
Buendía-Roldán I; Ruiz V; Sierra P; Montes E; Ramírez R; Vega A; Salgado A; Vargas MH; Mejía M; Pardo A; Selman M
PLoS One; 2016; 11(12):e0168552. PubMed ID: 27977812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
